Literature DB >> 8720916

Superoxide anion and endothelial regulation of arterial tone.

Z S Katusic1.   

Abstract

Evidence continues to accumulate on the importance of paracrine substances formed in the endothelium in regulation of the vascular system. Mechanisms that govern the balance between relaxing and contracting factors are important for understanding the regulation of blood vessel tone in health and disease. Chemical antagonism between superoxide anions and nitric oxide has been recognized as a potentially important modulator of vascular reactivity as well as being a source of peroxynitrite, a potent oxidant. In several models of vascular diseases, impairment of endothelium-dependent relaxations and promotion of endothelium-dependent contractions has been ascribed to increased production of superoxide anions. In pathologic conditions, increased production of superoxide anions may be responsible for an impairment of balance between relaxing and contracting factors favoring an increase in arterial tone. In this review the role of superoxide anions in modulation of endothelial mechanisms responsible for regulation of arterial tone will be discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8720916     DOI: 10.1016/0891-5849(96)02116-8

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  32 in total

1.  Hyperoxic vasoconstriction in the brain is mediated by inactivation of nitric oxide by superoxide anions.

Authors:  S Yu Zhilyaev; A N Moskvin; T F Platonova; D R Gutsaeva; I V Churilina; I T Demchenko
Journal:  Neurosci Behav Physiol       Date:  2003-10

2.  Role of statins in cerebral vasospasm.

Authors:  T Sugawara; R Ayer; J H Zhang
Journal:  Acta Neurochir Suppl       Date:  2008

3.  Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.

Authors:  Ronald Klein; Chelsea E Myers; Kristine E Lee; Andrew D Paterson; Karen J Cruickshanks; Michael Y Tsai; Ronald E Gangnon; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2015-09       Impact factor: 7.389

4.  Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.

Authors:  Biljana Musicki; Melissa F Kramer; Robyn E Becker; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

Review 5.  Endothelial nitric oxide: protector of a healthy mind.

Authors:  Zvonimir S Katusic; Susan A Austin
Journal:  Eur Heart J       Date:  2013-12-18       Impact factor: 29.983

6.  Prostaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase.

Authors:  M Zou; M Jendral; V Ullrich
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 7.  Endothelium-dependent contractions in hypertension.

Authors:  Paul M Vanhoutte; Michel Feletou; Stefano Taddei
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 8.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

9.  eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally.

Authors:  Eugenia Mata-Greenwood; Chrystal Jenkins; Kathryn N Farrow; G Ganesh Konduri; James A Russell; Satyan Lakshminrusimha; Stephen M Black; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-09-02       Impact factor: 5.464

10.  Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats.

Authors:  Emilio A Herrera; Misha M Verkerk; Jan B Derks; Dino A Giussani
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.